X

Tesamorelin 10 mg

80,00 

Tesamorelin is a synthetic GHRH analogue studied for interaction with growth hormone secretion pathways in endocrine research models.

  HPLC Purity ≥99% | Lyophilized | Research grade | EU-based supply | Free EU shipping over €100

Vorrätig

Beschreibung

Stabilized GHRH analogue research peptide

Tesamorelin is a synthetic analogue of growth hormone–releasing hormone (GHRH) investigated for its interaction with endogenous growth hormone secretion pathways and hypothalamic–pituitary endocrine regulation. It belongs to the GHRH analogue research class and is commonly studied in laboratory models examining pulsatile GH release, IGF-1 signaling dynamics, and peptide-mediated endocrine modulation.

Researchers are particularly interested in Tesamorelin because of its modified structure designed to improve stability against enzymatic degradation compared to native GHRH peptides. Experimental models have explored its interaction with growth hormone signaling pathways, endocrine adaptation mechanisms, and metabolic regulation systems linked to GH-axis activity.

Tesamorelin is frequently investigated alongside compounds such as Ipamorelin and CJC-1295 in research models studying coordinated GH-axis signaling and comparative endocrine pathway interaction. Compared to GHRP compounds including GHRP-2 und GHRP-6, Tesamorelin primarily acts through GHRH receptor–mediated signaling rather than ghrelin receptor activation.

For a broader overview of growth hormone secretagogues, pulsatile GH signaling, and GHRH analogue research compounds, see our Growth hormone peptides research guide.

Research applications (investigational)

Tesamorelin has been investigated in preclinical and experimental settings for its involvement in:

  • Growth hormone–releasing hormone (GHRH) receptor signaling
  • Pulsatile endogenous GH release mechanisms
  • GH/IGF-1 axis modulation research
  • Hypothalamic–pituitary endocrine pathway studies
  • Endocrine and metabolic signaling interaction models
  • Comparative analysis of GHRH analogue compounds
  • Peptide-mediated metabolic regulation research

These areas reflect ongoing scientific investigation into endocrine and peptide signaling pathways rather than established applications.

Product characteristics

Purity: ≥ 99% (HPLC)
Appearance: white lyophilized powder
Molecular formula: C221H366N72O67S
Molecular weight: 5135.78
CAS No: 218949-48-5
Storage: store lyophilized powder at -20°C, protect from light and moisture. Reconstituted solution should be kept at 2–8°C and used within a short period.

Why choose our Tesamorelin

≥99% purity verified by HPLC
Produced in GMP-compliant facilities under strict QC protocols
Each batch carefully lab tested after production (Certificate of Analysis available under product images)
Freeze-dried (lyophilized) for maximum stability and storage consistency
Sealed in sterile research vials ready for reconstitution
Compatible with standard peptide reconstitution protocols using bacteriostatic water

Selected research references

  • Falutz J et al. “Effects of tesamorelin, a growth hormone-releasing factor analogue, in HIV-infected patients with abdominal fat accumulation.” Journal of Clinical Endocrinology & Metabolism, 2010.
  • Stanley TL et al. “Effects of tesamorelin on inflammatory markers in HIV patients with excess abdominal fat.” AIDS, 2011.
  • Koutkia P et al. “Growth hormone-releasing hormone in HIV-associated lipodystrophy.” Current Opinion in Endocrinology, Diabetes and Obesity, 2006.
  • Smith RG et al. “Growth hormone secretagogues: physiology and clinical relevance.” Trends in Endocrinology & Metabolism, 2005.

Related research context

Tesamorelin belongs to the GHRH analogue and growth hormone signaling research class, which includes peptides investigated for endocrine regulation, GH-axis modulation, and pulsatile hormone release mechanisms.
For a broader overview of GH signaling pathways and comparative peptide mechanisms, see our Growth hormone peptides research guide.
Researchers studying GH-axis interaction may also examine:

CJC-1295 (no DAC)
Ipamorelin
GHRP-2
GHRP-6

Browse all compounds in the Growth hormone secretagogues category.
Researchers investigating endocrine regulation may also explore compounds in the Metabolic research category, including GLP-1 and multi-pathway incretin agonists.

NOTE: This is for educational reference only and does not constitute medical advice.

Disclaimer
This product is sold for research purposes only. It is not intended to diagnose, treat, cure, or prevent any disease. Buyer assumes full responsibility for proper handling and use.

Rezensionen

Es gibt noch keine Rezensionen.

Schreibe die erste Rezension für „Tesamorelin 10 mg“

Deine E-Mail-Adresse wird nicht veröffentlicht. Erforderliche Felder sind mit * markiert

Ähnliche Produkte